10 months ago
SDGR
AnalystsDavid LebovitzDavid Lebovitz's Stock Forecasts
AnalystsDavid Lebovitz
Analyst Ranking
Bottom 16%
#3738 out of 4414 analysts
Average Return
-2.06%
Win Rate
41%26 out of 64
Risk vs Reward
Poor
Good
David Lebovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Clementia Pharmaceuticals IncCMTA | +202.87% | $8.70 | $26.35 | 2018-08-12 - 2019-04-17 | Strong Buy |
Avexis IncAVXS | +129.75% | $94.81 | $217.83 | 2017-08-02 - 2018-05-15 | Strong Buy |
Avexis IncAVXS | +124.59% | $96.99 | $217.83 | 2017-11-12 - 2018-05-15 | Strong Buy |
Epizyme IncEPZM | +72.91% | $5.50 | $1.49 | 2021-08-09 - 2022-08-09 | Strong Sell |
Avexis IncAVXS | +71.25% | $127.20 | $217.83 | 2018-03-05 - 2018-05-15 | Strong Buy |
David Lebovitz Analyst Color
Get additional color on David Lebovitz's coverage of popular stocks
10 months ago
PLRX
a year ago
ASND
David Lebovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bridgebio Pharma IncBBIO | 1 | Strong Buy | $42.00 | +45.63% | Initiates Coverage On | 22 days ago |
Ptc Therapeutics IncPTCT | 6 | Strong Sell | $17.00 | -22.34% | Downgrades | a month ago |
Alnylam Pharmaceuticals IncALNY | 19 | Strong Buy | $233.00 | +44.40% | Maintains | 2 months ago |
Ionis Pharmaceuticals IncIONS | 9 | Strong Buy | $60.00 | +24.12% | Upgrades | 4 months ago |
Incyte CorpINCY | 1 | Strong Buy | $82.00 | +55.60% | Initiates Coverage On | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 3 | Hold | $96.00 | +9.39% | Maintains | 5 months ago |
Schrodinger IncSDGR | 4 | Strong Buy | $50.00 | +59.95% | Maintains | 7 months ago |
Ascendis Pharma AASND | 8 | Strong Buy | $146.00 | +61.11% | Maintains | 8 months ago |
Pliant Therapeutics IncPLRX | 3 | Strong Buy | $50.00 | +253.11% | Maintains | 9 months ago |
Intellia Therapeutics IncNTLA | 2 | Hold | $39.00 | +26.83% | Upgrades | 10 months ago |
Mirum Pharmaceuticals IncMIRM | 2 | Strong Buy | $34.00 | N/A | Maintains | a year ago |
Immuneering CorpIMRX | 2 | Hold | $12.00 | N/A | Maintains | a year ago |
Blueprint Medicines CorpBPMC | 5 | Strong Sell | $41.00 | N/A | Downgrades | a year ago |
Arcutis Biotherapeutics IncARQT | 5 | Strong Buy | $36.00 | N/A | Maintains | 2 years ago |
Syndax Pharmaceuticals IncSNDX | 1 | Hold | $21.00 | N/A | Maintains | 2 years ago |
Karyopharm Therapeutics IncKPTI | 2 | Strong Buy | $27.00 | N/A | Maintains | 2 years ago |
Ironwood Pharmaceuticals IncIRWD | 5 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Avrobio IncAVRO | 3 | Strong Buy | $25.00 | N/A | Maintains | 2 years ago |
Epizyme IncEPZM | 2 | Strong Sell | $5.00 | N/A | Downgrades | 2 years ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Strong Buy | $57.00 | N/A | Maintains | 3 years ago |
Macrogenics IncMGNX | 1 | Strong Sell | $15.00 | N/A | Maintains | 3 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | $220.00 | N/A | Downgrades | 3 years ago |
Nabriva Therapeutics PLCNBRVF | 2 | Hold | $500.00 | N/A | Maintains | 3 years ago |
Zealand Pharma AZEAL | 1 | Strong Buy | $37.00 | N/A | Maintains | 4 years ago |
Clementia Pharmaceuticals IncCMTA | 2 | Strong Buy | $26.00 | N/A | Maintains | 5 years ago |
Avexis IncAVXS | 3 | Strong Buy | $129.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.